Funder
Medical Research Council (GB)
Publisher
Springer Science and Business Media LLC
Subject
Statistics, Probability and Uncertainty,Statistics and Probability
Reference22 articles.
1. Babb JS, Rogatko A (2001) Patient specific dosing in a cancer phase I clinical trial. Stat Med 20:2079–2090. doi:
10.1002/sim.848
2. Babb JS, Rogatko A (2004) Bayesian methods for phase I cancer clinical trials. In: Geller NL (ed) Advances in clinical trial biostatistics. Marcel Dekker, New York, pp 1–40
3. Babb JS, Rogatko A, Zacks S (1998) Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat Med 17(10):1103–1120
4. Bartroff J, Lai TL (2011) Incorporating individual and collective ethics into phase I cancer trial designs. Biometrics 67(2):596–603. doi:
10.1111/j.1541-0420.2010.01471.x
5. Carter SK (1973) Study design principles for the clinical evaluation of new drugs as developed by the chemotherapy programme of the National Cancer Institute. In: Staquet M (ed) The design of clinical trials in cancer therapy. Editions Scientifique Europe, pp 242–289
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early-Phase Oncology Trials: Why So Many Designs?;Journal of Clinical Oncology;2022-10-20
2. Bayesian Adaptive Designs for Phase I Trials;Principles and Practice of Clinical Trials;2022
3. A continual reassessment method without undue risk of toxicity;Communications in Statistics - Simulation and Computation;2021-01-29
4. Bayesian Adaptive Designs for Phase I Trials;Principles and Practice of Clinical Trials;2021
5. Bayesian Adaptive Designs for Phase I Trials;Principles and Practice of Clinical Trials;2021